You are here

  • Home
  • Archive
  • Volume 9, Issue 2
  • In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity

Alerts

Article menu

This article has a correction. Please see:

XML
Clinical/translational cancer immunotherapy
Original research
In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address